Fuse Medical Stock Performance

FZMD Stock  USD 0.04  0.01  33.33%   
Fuse Medical holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.93, which means possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Fuse Medical are expected to decrease slowly. On the other hand, during market turmoil, Fuse Medical is expected to outperform it slightly. Use Fuse Medical jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to analyze future returns on Fuse Medical.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Fuse Medical are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile primary indicators, Fuse Medical exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow1.2 M
Free Cash Flow-1.8 M
  

Fuse Medical Relative Risk vs. Return Landscape

If you would invest  6.00  in Fuse Medical on November 8, 2025 and sell it today you would lose (2.00) from holding Fuse Medical or give up 33.33% of portfolio value over 90 days. Fuse Medical is currently generating 4.3373% in daily expected returns and assumes 40.5793% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Fuse, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Fuse Medical is expected to generate 53.03 times more return on investment than the market. However, the company is 53.03 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Fuse Medical Target Price Odds to finish over Current Price

The tendency of Fuse Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.04 90 days 0.04 
about 65.54
Based on a normal probability distribution, the odds of Fuse Medical to move above the current price in 90 days from now is about 65.54 (This Fuse Medical probability density function shows the probability of Fuse Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Fuse Medical has a beta of -0.93. This usually indicates In addition to that Fuse Medical has an alpha of 3.587, implying that it can generate a 3.59 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Fuse Medical Price Density   
       Price  

Predictive Modules for Fuse Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fuse Medical. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0440.62
Details
Intrinsic
Valuation
LowRealHigh
0.000.0440.62
Details
Naive
Forecast
LowNextHigh
0.00010.0140.59
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.050.08
Details

Fuse Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Fuse Medical is not an exception. The market had few large corrections towards the Fuse Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Fuse Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Fuse Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
3.59
β
Beta against Dow Jones-0.93
σ
Overall volatility
0.02
Ir
Information ratio 0.09

Fuse Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fuse Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fuse Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Fuse Medical is way too risky over 90 days horizon
Fuse Medical has some characteristics of a very speculative penny stock
Fuse Medical appears to be risky and price may revert if volatility continues
Fuse Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported the previous year's revenue of 20.41 M. Net Loss for the year was (1.59 M) with profit before overhead, payroll, taxes, and interest of 11.94 M.
Fuse Medical currently holds about 604 K in cash with (1.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 88.0% of the company shares are held by company insiders

Fuse Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fuse Pink Sheet often depends not only on the future outlook of the current and potential Fuse Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fuse Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding70.2 M
Cash And Short Term Investments553.2 K

Fuse Medical Fundamentals Growth

Fuse Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Fuse Medical, and Fuse Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fuse Pink Sheet performance.

About Fuse Medical Performance

By analyzing Fuse Medical's fundamental ratios, stakeholders can gain valuable insights into Fuse Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Fuse Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Fuse Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Fuse Medical, Inc. manufactures and distributes medical device implants in the United States. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical operates under Medical Devices classification in the United States and is traded on OTC Exchange.

Things to note about Fuse Medical performance evaluation

Checking the ongoing alerts about Fuse Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Fuse Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Fuse Medical is way too risky over 90 days horizon
Fuse Medical has some characteristics of a very speculative penny stock
Fuse Medical appears to be risky and price may revert if volatility continues
Fuse Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company reported the previous year's revenue of 20.41 M. Net Loss for the year was (1.59 M) with profit before overhead, payroll, taxes, and interest of 11.94 M.
Fuse Medical currently holds about 604 K in cash with (1.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 88.0% of the company shares are held by company insiders
Evaluating Fuse Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Fuse Medical's pink sheet performance include:
  • Analyzing Fuse Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fuse Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Fuse Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Fuse Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fuse Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Fuse Medical's pink sheet. These opinions can provide insight into Fuse Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Fuse Medical's pink sheet performance is not an exact science, and many factors can impact Fuse Medical's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Fuse Pink Sheet analysis

When running Fuse Medical's price analysis, check to measure Fuse Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fuse Medical is operating at the current time. Most of Fuse Medical's value examination focuses on studying past and present price action to predict the probability of Fuse Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fuse Medical's price. Additionally, you may evaluate how the addition of Fuse Medical to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios